Researchers from TERM group at LU gave an invited talk on ‘A New Augmentation Method for Improved Screw Fixation in Fragile Bone With...

Background The treatments for trochanteric fractures try to regain early mobility and limit morbidity and risk of re-operations. The most...

The term group at LU has published the first proof-of-concept study describing Moroxite F AB groundbreaking implant fixation technology...

Pertrochanteric fractures (TF) due to osteoporosis constitute nearly half of all proximal femur fractures. TFs are treated with a...

Almi Invest is investing four million kronor in Moroxite F for developing a new treatment for osteoporosis. Fåhraeus Startup & Growth is...

Fåhraeus Startup & Growth fund invests six million Swedish crowns in Moroxite F.

Per trochanteric fractures are common in an ageing population with osteoporosis and account for about half of all hip fractures....

This research aims to investigate nonionic hyperbranched polyesters (HBPs) derived from indole and lignin resources as new nontoxic...

Due to the aging population, hip fracture incidence has been increasing over the past decades. Measurements of bone mineral density with...

The bone tissue formed at the contact interface with metallic implants, particularly its 3D microstructure, plays a pivotal role for the...

CaS/HA can improve the fixation of a dynamic hip screw.

Ceramic biomaterials are promising alternatives to bone autografts. However, limited bioactivity affects their performance. Therefore,...

Bone morphogenic proteins (BMPs) are the only true osteoinductive molecules. Despite being tremendously potent, their clinical use has...

Osteoporosis often leads to fragility fractures of the hip, resulting in impaired quality of life and increased mortality. Augmenting the...

Bone is a dynamic tissue with a quarter of the trabecular and a fifth of the cortical bone being replaced continuously each year in a...